A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

NCT02518139 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1060

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: TD-4208
DRUG: Tiotropium

Sponsor

Mylan Inc.

Collaborators

[object Object]